Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.

Source:http://linkedlifedata.com/resource/pubmed/id/9166480

Download in:

View as

General Info

PMID
9166480